HAVANA, Cuba, Aug 3 (ACN) A total of 2,680,648 Cubans have already completed the three-dose scheme of one of the immunogens developed in the country against COVID-19.
According to information from the Ministry of Public Health (MINSAP), published today on its website, as of August 1, 4,155,261 people had received at least one dose of the vaccine candidates Soberana 02 and Soberana Plus, or the Abdala vaccine; and 3,225,507 had two.
In total, over 10 million doses have been administered, between the health intervention in groups and territories at risk, the intervention study, clinical trials of vaccine candidates, and mass vaccination.
Since May of this year, when the health intervention began, to date, 8,813,860 doses have been administered in this process.
Likewise, the intervention study involving health workers, BioCubaFarma and other risk groups in the provinces of Havana, Santiago de Cuba, Granma and Guantánamo, has included 448,191 doses.
In the clinical trials with the most advanced vaccine candidates, which took place in Havana, Santiago, Granma and Guantanamo, 149,364 doses were administered, excluding from this figure the placebos applied during the studies.
Finally, and after the Emergency Use Authorization for the Cuban Abdala vaccine, the massive vaccination process in the country, which began on July 29, has included 649,821 doses of this national drug.